Merakris Therapeutics Receives USPTO Notice of Allowance for Foundational Patent Supporting MTX-001 Biologic Drug Platform
Merakris Therapeutics Receives USPTO Notice of Allowance for Foundational Patent Supporting MTX-001 Biologic Drug Platform Patent strengthens intellectual property for investigational new drug MTX-001 — Phase 2 clinical trial for chronic venous leg ulcers ongoing GlobeNewswire August 19, 2025 RESEARCH TRIANGLE PARK, N.C., Aug. 19, 2025 (GLOBE NEWSWIRE) — Merakris Therapeutics today announced the United […]